GSE196035 GSE196037 MEN1 inhibition 2 v 4 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE196035_GSE196037_MEN1 inhibition_2_v_4_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE196035_GSE196037_MEN1 inhibition_2_v_4_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE196035_GSE196037_MEN1 inhibition_2_v_4_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE196035_GSE196037_MEN1 inhibition_2_v_4_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene

Gene

NmrA like redox sensor 2, pseudogene

Gene

SATB2 antisense RNA 1

Gene

chromosome 6 open reading frame 47

Gene

SUGT1P4-STRA6LP-CCDC180 readthrough

Gene

HMGA2 antisense RNA 1

Gene

B3GALT5 antisense RNA 1

Gene

SDHA pseudogene 3

Gene

MRPL23 antisense RNA 1

Gene

MIR3667 host gene

  • Gene

    Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene


  • Gene

    NmrA like redox sensor 2, pseudogene


  • Gene

    SATB2 antisense RNA 1


  • Gene

    chromosome 6 open reading frame 47


  • Gene

    SUGT1P4-STRA6LP-CCDC180 readthrough


  • Gene

    HMGA2 antisense RNA 1


  • Gene

    B3GALT5 antisense RNA 1


  • Gene

    SDHA pseudogene 3


  • Gene

    MRPL23 antisense RNA 1


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.